A new cholesterol pill could change the fight against heart disease
Last week, the Food and Drug Administration (FDA) approved a small pill called enlicitide. It is a tablet…
FDA is urged by advocacy group to ban DTC prescription drug ads
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
MAHA’s mental health rhetoric masks an alarming agenda
At a May MAHA Institute summit organized around the theme of “overmedicalization,” the health secretary announced an action…
Google is better at playing the AI regulations game
Today, the European Union ordered Google to give its AI rivals greater access to Android, the open-source operating…
Google and Epic give up fighting — third-party Android app stores are coming next week
Epic Games and Google have just jointly withdrawn their attempt to retroactively settle the lawsuit that’s changing how…
The Trump admin’s biofuels policy could be a disaster for the world’s rainforests
The modern soybean is one of the world’s miracle technologies, capable of cheaply, efficiently, and healthfully supplying protein…
Kennedy presses ahead with plans to reduce antidepressant use
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
Airlines depend on doctor volunteers
On three of my last seven flights, a request came over the cabin speakers: “Is there a doctor…
I spent a week using the Trump phone — it sucks
The Trump phone was never a serious phone. Not when it was announced last June, in dodgy renders…
I finally got my Trump phone
12 months, 16 days, 21 hours, and 54 minutes after I first heard about Trump Mobile’s T1 Phone…
As presidential fitness test returns for students, so do old questions
WASHINGTON — The presidential fitness test, a divisive hallmark of children’s education from the 1960s to the 2010s,…
Medicare’s Bridge program now covers weight-loss drugs for $50. The US economy is in for a shock.
The latest breakthrough for GLP-1 drugs isn’t scientific. It’s financial. As of July 1, Medicare is providing coverage…